輸入代號或公司名稱後按 Enter
4137

麗豐-KY

-1.10 (-1.44%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
75.20154成交張數11.14本益比1.26股價淨值比13.30%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q21.51-42.4%6.751.2512.7%2.37%11.92%
2026Q11.41107.3%7.861.1612.7%2.14%11.47%
2025Q41.83161.4%7.131.5113.7%2.99%10.87%
2025Q32.0031.6%6.001.6516.1%3.57%9.58%
2025Q22.62-2.2%5.522.1622.7%4.27%9.45%
2025Q10.68-25.3%5.580.567.0%0.99%8.22%
2024Q40.70-81.4%5.810.585.7%1.06%8.84%
2024Q31.52-31.7%8.871.2612.3%2.34%13.50%
2024Q22.6836.2%9.572.1621.2%4.07%15.49%
2024Q10.91-81.8%8.860.727.2%1.37%13.60%
2023Q43.7647.1%12.953.0024.4%5.87%21.09%
2023Q32.2321.7%11.741.7914.5%3.67%19.14%
2023Q21.97330.4%11.351.5814.0%3.25%19.73%
2023Q15.0032.0%9.843.9742.0%8.19%14.81%
2022Q42.55-40.0%8.622.0419.4%4.36%14.30%
2022Q31.83-61.2%10.321.4612.0%3.16%17.65%
2022Q20.46-88.8%13.210.364.8%0.73%22.35%
2022Q13.79-2.6%16.843.0329.3%5.76%26.41%
2021Q44.255.4%16.943.4022.6%7.07%28.83%
2021Q34.7128.4%16.723.7727.1%7.88%31.19%
2021Q24.0931.6%15.683.2825.9%6.83%29.71%
2021Q13.89223.1%14.703.1128.0%6.84%25.93%
2020Q44.03-14.5%12.013.2322.3%7.72%21.83%
2020Q33.67-14.4%12.702.9328.3%7.84%25.26%
2020Q23.11-25.3%13.312.4827.0%6.28%28.64%
2020Q11.20-74.6%14.370.9614.7%2.20%25.58%
2019Q44.7218.2%17.903.7726.6%8.92%33.72%
2019Q34.289.7%17.183.4327.0%8.57%35.10%
2019Q24.1620.4%16.803.3325.8%7.81%36.11%
2019Q14.7420.2%16.103.8032.6%8.71%30.22%
2018Q43.9974.8%15.303.1923.9%8.12%32.10%
2018Q33.90105.8%13.593.1227.4%8.57%30.60%
2018Q23.4672.3%11.592.7525.3%7.40%27.67%
2018Q13.94236.5%10.133.1230.8%8.44%21.89%
2017Q42.2948.4%7.361.8017.5%5.33%16.56%
2017Q31.9017.2%6.621.5119.3%4.69%15.42%
2017Q22.014.1%6.341.5920.8%4.87%15.25%
2017Q11.17-71.0%6.260.9312.9%2.66%13.07%
2016Q41.549.131.2315.1%3.48%
2016Q31.621.3018.3%3.71%